Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Short exposure within limits may be acceptable, but verify
Yes, tirzepatide may reduce oral contraceptive effectiveness during the first 4 weeks after starting the medication and for 4 weeks after each dose increase due to delayed gastric emptying
One of our doctors will review your answers, why you want to switch, and current health
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
After reconstitution: Keep refrigerated
US$ 22.76
US$ 24.09
US$ 25.48
